3 Matching Annotations
  1. Nov 2024
  2. www.sciencedirect.com www.sciencedirect.com
    Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy
    1
    1. scibot 11 Nov 2024
      RRID:AB_1279107

      DOI: 10.1016/j.ccell.2024.10.008

      Resource: (BioLegend Cat# 131508, RRID:AB_1279107)

      Curator: @scibot

      SciCrunch record: RRID:AB_1279107

      What is this?
      RRID:AB_1279107
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610824003969
  3. Jul 2023
  4. www.sciencedirect.com www.sciencedirect.com
    TCR-independent CD137 (4-1BB) signaling promotes CD8+-exhausted T cell proliferation and terminal differentiation
    1
    1. scibot 01 Jul 2023
      RRID:AB_1279107

      DOI: 10.1016/j.immuni.2023.06.007

      Resource: (BioLegend Cat# 131508, RRID:AB_1279107)

      Curator: @scibot

      SciCrunch record: RRID:AB_1279107

      What is this?
      RRID:AB_1279107
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1074761323002649
  5. May 2021
  6. www.sciencedirect.com www.sciencedirect.com
    Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy
    1
    1. scibot 07 May 2021
      RRID:AB_1279107

      DOI: 10.1016/j.immuni.2020.09.006

      Resource: (BioLegend Cat# 131508, RRID:AB_1279107)

      Curator: @scibot

      SciCrunch record: RRID:AB_1279107

      What is this?
      RRID:AB_1279107
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1074761320304003